| Product NDC: | 0591-3798 |
| Proprietary Name: | Ipratropium Bromide |
| Non Proprietary Name: | Ipratropium Bromide |
| Active Ingredient(s): | .5 mg/2.5mL & nbsp; Ipratropium Bromide |
| Administration Route(s): | RESPIRATORY (INHALATION) |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0591-3798 |
| Labeler Name: | Watson Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075693 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110301 |
| Package NDC: | 0591-3798-83 |
| Package Description: | 1 POUCH in 1 CARTON (0591-3798-83) > 25 VIAL in 1 POUCH > 2.5 mL in 1 VIAL |
| NDC Code | 0591-3798-83 |
| Proprietary Name | Ipratropium Bromide |
| Package Description | 1 POUCH in 1 CARTON (0591-3798-83) > 25 VIAL in 1 POUCH > 2.5 mL in 1 VIAL |
| Product NDC | 0591-3798 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Ipratropium Bromide |
| Dosage Form Name | SOLUTION |
| Route Name | RESPIRATORY (INHALATION) |
| Start Marketing Date | 20110301 |
| Marketing Category Name | ANDA |
| Labeler Name | Watson Laboratories, Inc. |
| Substance Name | IPRATROPIUM BROMIDE |
| Strength Number | .5 |
| Strength Unit | mg/2.5mL |
| Pharmaceutical Classes | Anticholinergic [EPC],Cholinergic Antagonists [MoA] |